Leila Alland
2021
In 2021, Leila Alland earned a total compensation of $1.4M as Chief Medical Officer at PMV Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $229,150 |
|---|---|
| Option Awards | $715,059 |
| Salary | $456,083 |
| Total | $1,400,292 |
Alland received $715.1K in option awards, accounting for 51% of the total pay in 2021.
Alland also received $229.2K in non-equity incentive plan and $456.1K in salary.
Rankings
In 2021, Leila Alland's compensation ranked 7,548th out of 12,415 executives tracked by ExecPay. In other words, Alland earned more than 39.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,548 out of 12,415 | 39th |
Division Manufacturing | 3,324 out of 5,505 | 40th |
Major group Chemicals And Allied Products | 1,473 out of 2,375 | 38th |
Industry group Drugs | 1,311 out of 2,096 | 38th |
Industry Pharmaceutical Preparations | 967 out of 1,546 | 38th |
Source: SEC filing on April 28, 2023.
Alland's colleagues
We found two more compensation records of executives who worked with Leila Alland at PMV Pharmaceuticals in 2021.